The role of antioxidants in chemical carcinogenesisITO, N; HIROSE, M.Japanese journal of cancer research. 1987, Vol 78, Num 10, pp 1011-1026, issn 0910-5050Article

Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growthRUSSELL, D. H; DAVIDSON, I. W. F.Drug metabolism reviews (Softcover ed.). 1985, Vol 16, Num 1-2, pp 1-88, issn 0360-2532Article

Antibody therapies for cancerBONAVIDA, Benjamin.Oncogene (Basingstoke). 2007, Vol 26, Num 25, issn 0950-9232, 179 p.Serial Issue

Normal and malignant hematopoiesisFRIEDMAN, A. D.Oncogene (Basingstoke). 2007, Vol 26, Num 47, issn 0950-9232, 167 p.Serial Issue

Polymorphisms and cancerMURPHY, Maureen.Oncogene (Basingstoke). 2006, Vol 25, Num 11, issn 0950-9232, 100 p.Serial Issue

mTOR signallingPROUD, Chris.Oncogene (Basingstoke). 2006, Vol 25, Num 48, issn 0950-9232, 103 p.Serial Issue

Polo-like kinasesDAI, Wei.Oncogene (Basingstoke). 2005, Vol 24, Num 2, issn 0950-9232, 101 p.Serial Issue

Ubiquitination in cancerSETH, Arun.Oncogene (Basingstoke). 2004, Vol 23, Num 11, issn 0950-9232, 160 p.Serial Issue

Src family kinasesPARSONS, Sarah J; PARSONS, J. Thomas.Oncogene (Basingstoke). 2004, Vol 23, Num 48, issn 0950-9232, 129 p.Serial Issue

RNA interference-based functional genomics in cancer researchDOWNWARD, Julian.Oncogene (Basingstoke). 2004, Vol 23, Num 51, issn 0950-9232, 78 p.Serial Issue

Molecular targets in radiation oncologySCHMIDT-ULLRICH, Rupert K.Oncogene (Basingstoke). 2003, Vol 22, Num 37, issn 0950-9232, 199 p.Serial Issue

Biomolecular strategies for therapeutic intervention in cancerGIORDANO, Antonio; MAIO, Michele.Oncogene (Basingstoke). 2003, Vol 22, Num 42, issn 0950-9232, 193 p.Serial Issue

DNA Methylation and CancerJONES, Peter A.Oncogene (Basingstoke). 2002, Vol 21, Num 35, issn 0950-9232, 159 p.Serial Issue

Role for EPS8 in squamous carcinogenesisHUIXIN WANG; PATEL, Vyomesh; MIYAZAKI, Hiroshi et al.Carcinogenesis (New York. Print). 2009, Vol 30, Num 1, pp 165-174, issn 0143-3334, 10 p.Article

The role of genetic testing in the prediction of response to EGFR inhibitors in NSCLCHIRSCH, Fred R.Oncogene (Basingstoke). 2009, Vol 28, issn 0950-9232, 47 p., SUP1Serial Issue

Apoptosis - Part 1REED, John C.Oncogene (Basingstoke). 2008, Vol 27, Num 48, issn 0950-9232, 123 p.Serial Issue

Cell death regulation by BH3-only family proteinsCHINNADURAI, G.Oncogene (Basingstoke). 2008, Vol 27, issn 0950-9232, 177 p., SUP1Serial Issue

Cancer: Biology and therapeutics. A tribute to George Vande WoudeDUESBERY, Nicholas S; TEH, Bin T.Oncogene (Basingstoke). 2007, Vol 26, Num 9, issn 0950-9232, 106 p.Serial Issue

Cancer genetics and epigenetics: histone acetyltransferases and deacetylasesYANG, Xiang-Jiao; SETO, Edward.Oncogene (Basingstoke). 2007, Vol 26, Num 37, issn 0950-9232, 246 p.Serial Issue

MicroRNAsHUTVAGNER, Gyorgy.Oncogene (Basingstoke). 2006, Vol 25, Num 46, issn 0950-9232, 76 p.Serial Issue

Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesisKO, Michael A; ROSARIO, Carla O; HUDSON, John W et al.Nature genetics. 2005, Vol 37, Num 8, pp 883-888, issn 1061-4036, 6 p.Article

AKT signaling in normal and malignant cellsTESTA, Joseph R; TSICHLIS, Philip N.Oncogene (Basingstoke). 2005, Vol 24, Num 50, issn 0950-9232, 114 p.Serial Issue

Viruses: tools for tumor target discovery, and agents for oncolytic therapiesO'SHEA, Clodagh C.Oncogene (Basingstoke). 2005, Vol 24, Num 52, issn 0950-9232, 186 p.Serial Issue

Translation and cancerPANDOLFI, Pier Paolo.Oncogene (Basingstoke). 2004, Vol 23, Num 18, issn 0950-9232, 133 p.Serial Issue

The RUNX gene familyITO, Yoshiaki; BAE, Suk-Chul.Oncogene (Basingstoke). 2004, Vol 23, Num 24, issn 0950-9232, 162 p.Serial Issue